Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-75
SponsorJetema Co., Ltd.

About this trial

Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds

Eligibility criteria

Qualifiers

Adults aged 19 to 75 years

Voluntarily provided written informed consent

Moderate to severe symmetrical nasolabial folds (WSRS score 3 or 4 on both sides)

Agree to discontinue other facial dermatologic treatments (e.g., fillers, botulinum toxin, laser) during the study

Disqualifiers

Untreated scars or facial skin infections/diseases affecting the mid/lower face within the past year

History of severe allergy or hypersensitivity to device components

Facial invasive procedures within the past 6 months (including surgery, laser, botulinum toxin)

Use of certain medications (anticoagulants, immunosuppressants, steroids) within specified washout periods

Trial design

Treatments tested in this trial

  • JTM104
  • Juvederm® ULTRA PLUS XC

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators